Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials

Activation of the renin-angiotensin system plays a major role in cardiovascular morbidity and mortality. Recently, angiotensin II receptor blockers (ARBs) have been the subject of a number of large clinical cardiovascular outcome trials, indicating beneficial effects of ARBs with more than 384,000 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumhäkel, Magnus, Böhm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141911/
https://www.ncbi.nlm.nih.gov/pubmed/21796253
http://dx.doi.org/10.2147/VHRM.S17168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141911/
https://www.ncbi.nlm.nih.gov/pubmed/21796253
http://dx.doi.org/10.2147/VHRM.S17168

Ejemplares similares